vs
Aclarion, Inc.（ACON）与BioNexus Gene Lab Corp（BGLC）财务数据对比。点击上方公司名可切换其他公司
BioNexus Gene Lab Corp的季度营收约是Aclarion, Inc.的26.2倍（$483.8K vs $18.5K）。BioNexus Gene Lab Corp净利率更高（-214.2% vs -10223.7%，领先10009.6%）。Aclarion, Inc.同比增速更快（80.6% vs -80.8%）。过去两年Aclarion, Inc.的营收复合增速更高（35.2% vs -54.9%）
Aclarion, Inc.是一家专注于慢性下背痛诊疗的医疗科技企业，核心产品基于专利磁共振波谱技术，可精准识别患者的疼痛性椎间盘，服务美国市场的医疗机构与患者，业务覆盖慢性疼痛管理、脊柱护理两大核心领域。
BioNexus Gene Lab Corp是一家生物技术企业，主营分子诊断检测、基因分析及相关生命科学解决方案，服务客户涵盖医疗机构、科研机构及个人用户，核心市场主要覆盖东南亚地区。
ACON vs BGLC — 直观对比
营收规模更大
BGLC
是对方的26.2倍
$18.5K
营收增速更快
ACON
高出161.4%
-80.8%
净利率更高
BGLC
高出10009.6%
-10223.7%
两年增速更快
ACON
近两年复合增速
-54.9%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $18.5K | $483.8K |
| 净利润 | $-1.9M | $-1.0M |
| 毛利率 | 9.7% | -0.8% |
| 营业利润率 | -10785.8% | -213.5% |
| 净利率 | -10223.7% | -214.2% |
| 营收同比 | 80.6% | -80.8% |
| 净利润同比 | 5.0% | -197.5% |
| 每股收益（稀释后） | $1.39 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACONBGLC
| Q4 25 | $18.5K | $483.8K | ||
| Q3 25 | $18.9K | $2.5M | ||
| Q2 25 | $19.3K | $2.3M | ||
| Q1 25 | $19.0K | $2.1M | ||
| Q4 24 | $10.2K | $2.5M | ||
| Q3 24 | $14.4K | $2.6M | ||
| Q2 24 | $11.0K | $2.0M | ||
| Q1 24 | $10.1K | $2.4M |
净利润ACONBGLC
| Q4 25 | $-1.9M | $-1.0M | ||
| Q3 25 | $-1.7M | $-709.0K | ||
| Q2 25 | $-1.6M | $-616.2K | ||
| Q1 25 | $-2.0M | $-623.3K | ||
| Q4 24 | $-2.0M | $-348.3K | ||
| Q3 24 | $-1.4M | $-1.3M | ||
| Q2 24 | $-1.2M | $199.1K | ||
| Q1 24 | $-2.4M | $-103.8K |
毛利率ACONBGLC
| Q4 25 | 9.7% | -0.8% | ||
| Q3 25 | 23.2% | 14.8% | ||
| Q2 25 | 26.6% | 16.3% | ||
| Q1 25 | -23.6% | 16.1% | ||
| Q4 24 | -100.9% | 12.3% | ||
| Q3 24 | -48.1% | 12.4% | ||
| Q2 24 | -112.3% | 14.6% | ||
| Q1 24 | -92.6% | 15.3% |
营业利润率ACONBGLC
| Q4 25 | -10785.8% | -213.5% | ||
| Q3 25 | -9666.2% | -27.6% | ||
| Q2 25 | -8988.6% | -27.0% | ||
| Q1 25 | -7856.0% | -28.9% | ||
| Q4 24 | -17652.7% | -16.5% | ||
| Q3 24 | -8995.3% | -50.9% | ||
| Q2 24 | -10350.6% | 13.1% | ||
| Q1 24 | -12609.3% | -3.3% |
净利率ACONBGLC
| Q4 25 | -10223.7% | -214.2% | ||
| Q3 25 | -9008.0% | -27.9% | ||
| Q2 25 | -8285.9% | -27.3% | ||
| Q1 25 | -10728.4% | -29.2% | ||
| Q4 24 | -19444.6% | -13.8% | ||
| Q3 24 | -9482.7% | -51.1% | ||
| Q2 24 | -11285.0% | 10.1% | ||
| Q1 24 | -23720.6% | -4.4% |
每股收益（稀释后）ACONBGLC
| Q4 25 | $1.39 | — | ||
| Q3 25 | $-2.93 | $-0.40 | ||
| Q2 25 | $-2.75 | $-0.34 | ||
| Q1 25 | $-9.32 | $-0.04 | ||
| Q4 24 | $-809.36 | $0.55 | ||
| Q3 24 | $-1321.49 | $-0.75 | ||
| Q2 24 | $-1362.83 | $0.11 | ||
| Q1 24 | $-3985.22 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.0M | $2.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $12.8M | $8.6M |
| 总资产 | $13.7M | $9.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACONBGLC
| Q4 25 | $12.0M | $2.5M | ||
| Q3 25 | $11.3M | — | ||
| Q2 25 | $12.8M | — | ||
| Q1 25 | $14.8M | — | ||
| Q4 24 | $453.7K | $2.9M | ||
| Q3 24 | $1.3M | — | ||
| Q2 24 | $1.2M | — | ||
| Q1 24 | $2.1M | — |
股东权益ACONBGLC
| Q4 25 | $12.8M | $8.6M | ||
| Q3 25 | $12.5M | $6.8M | ||
| Q2 25 | $14.2M | $7.5M | ||
| Q1 25 | $15.8M | $7.8M | ||
| Q4 24 | $970.1K | $8.3M | ||
| Q3 24 | $2.5M | $9.4M | ||
| Q2 24 | $1.6M | $9.5M | ||
| Q1 24 | $2.5M | $9.3M |
总资产ACONBGLC
| Q4 25 | $13.7M | $9.3M | ||
| Q3 25 | $13.2M | $7.6M | ||
| Q2 25 | $14.8M | $9.4M | ||
| Q1 25 | $16.5M | $9.5M | ||
| Q4 24 | $2.1M | $10.4M | ||
| Q3 24 | $3.2M | $11.0M | ||
| Q2 24 | $3.1M | $11.1M | ||
| Q1 24 | $3.7M | $11.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.6M | $961.1K |
| 自由现金流经营现金流 - 资本支出 | — | $960.1K |
| 自由现金流率自由现金流/营收 | — | 198.5% |
| 资本支出强度资本支出/营收 | — | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.9M |
8季度趋势，按日历期对齐
经营现金流ACONBGLC
| Q4 25 | $-1.6M | $961.1K | ||
| Q3 25 | $-1.2M | $-1.2M | ||
| Q2 25 | $-1.9M | $-737.9K | ||
| Q1 25 | $-2.5M | $-824.1K | ||
| Q4 24 | $-922.9K | $219.2K | ||
| Q3 24 | $-1.1M | $-1.6M | ||
| Q2 24 | $-1.1M | $-672.3K | ||
| Q1 24 | $-2.2M | $-37.2K |
自由现金流ACONBGLC
| Q4 25 | — | $960.1K | ||
| Q3 25 | $-1.2M | $-1.2M | ||
| Q2 25 | — | $-759.4K | ||
| Q1 25 | — | $-833.1K | ||
| Q4 24 | — | $215.2K | ||
| Q3 24 | — | $-1.8M | ||
| Q2 24 | — | $-674.1K | ||
| Q1 24 | — | $-59.1K |
自由现金流率ACONBGLC
| Q4 25 | — | 198.5% | ||
| Q3 25 | -6164.6% | -48.9% | ||
| Q2 25 | — | -33.6% | ||
| Q1 25 | — | -39.0% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | — | -68.5% | ||
| Q2 24 | — | -34.1% | ||
| Q1 24 | — | -2.5% |
资本支出强度ACONBGLC
| Q4 25 | — | 0.2% | ||
| Q3 25 | 38.6% | 0.2% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 0.0% | 7.6% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.9% |
现金转化率ACONBGLC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -3.38× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
